GlassScriptPhysician profile
Jonathan N Sembrano
NPI 1932113487
$5,497.73
in general payments reported to CMS, 2019-2025
12 companies · $3,291 in 2025
The $3,291 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.95 · 2020: $22.25 · 2021: $267 · 2022: $1,222 · 2023: $265 · 2024: $350 · 2025: $3,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,388 · Travel and Lodging: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,388.21 |
| Travel and Lodging | $1,517.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $2,484.86 | 2023-2025 | |
| Smaio Sa | $913.67 | 2022 | |
| Medtronic, INC. | $686.70 | 2021-2025 | Mazor X System, Unid_pass, Stealthstation S8 Platform |
| Smaio USA Corporation | $416.02 | 2025 | |
| Nuvasive, INC. | $408.91 | 2021-2023 | Xlif |
| Alphatec Spine, INC | $192.28 | 2022 | |
| Kuros Biosciences USA, INC | $127.37 | 2025 | Magnetos |
| Kerecis Limited | $111.56 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic USA, INC. | $103.20 | 2019-2020 | |
| Orthofix Medical, INC. | $28.17 | 2023-2025 | Spinal-Stim, Spinal-Stim |
| Depuy Synthes Sales INC. | $24.99 | 2025 | Teligen |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Sembrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.